Outlook Therapeutics Inc (NASDAQ:OTLK)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting 0.25. At the close of
Bon Natural Life Ltd (NASDAQ:BON)’s traded shares stood at 0.87 million during the last session, with the company’s beta value hitting -0.51. At the close
Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 1.69. At the close of
Cidara Therapeutics Inc (NASDAQ:CDTX)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting 1.17. At the close of
Larimar Therapeutics Inc (NASDAQ:LRMR)’s traded shares stood at 0.52 million during the last session, with the company’s beta value hitting 0.92. At the close of
Royalty Management Holding Corp (NASDAQ:RMCO)’s traded shares stood at 0.36 million during the last session, with the company’s beta value hitting -0.19. At the close
Claros Mortgage Trust Inc (NYSE:CMTG)’s traded shares stood at 0.36 million during the last session, with the company’s beta value hitting 1.22. At the close
Zevia PBC (NYSE:ZVIA)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 0.91. At the close of trading,
SkyWater Technology Inc (NASDAQ:SKYT)’s traded shares stood at 0.55 million during the last session, with the company’s beta value hitting 3.40. At the close of
Perspective Therapeutics Inc (AMEX:CATX)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 1.18. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne